Active substances
Chlordiazepoxide + Clidinium
- SFDA 2
- US FDA 14
- Health Canada 1
- US price lines 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| LIBRAX TABLET | 2.5, 5 mg | Tablet · Oral use | 30 Blister | SAR 16.85 | Generic · Prescription | VALEANT PHARMACEUTICALS | Withdrawn by MAH · Not Marketed |
| POXIDIUM TAB | 2.5, 5 mg | Tablet · Oral use | 30 Blister | SAR 5.15 | NCE · Prescription | Hikma Pharmaceuticals PLC | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| LIBRAX | 5MG;2.5MG | capsule · oral | BAUSCH | Prescription | 1 Sep 1966 |
| CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 5MG;2.5MG | capsule · oral | NUVO PHARMS INC | Prescription | 7 Jul 2020 |
| CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 5MG;2.5MG | capsule · oral | MISEMER | Prescription | 29 Jul 2020 |
| CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 5MG;2.5MG | capsule · oral | CHARTWELL RX | Prescription | 20 Oct 2020 |
| CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 5MG;2.5MG | capsule · oral | ALKEM LABS LTD | Prescription | 26 Apr 2021 |
| CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 5MG;2.5MG | capsule · oral | DR REDDYS | Prescription | 10 May 2021 |
| CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 5MG;2.5MG | capsule · oral | AMNEAL | Prescription | 25 Oct 2021 |
| CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 5MG;2.5MG | capsule · oral | MICRO LABS | Prescription | 19 Jul 2022 |
| CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 5MG;2.5MG | capsule · oral | COREPHARMA | Prescription | 29 Jul 2022 |
| CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 5MG;2.5MG | capsule · oral | AUROBINDO PHARMA LTD | Prescription | 14 Sep 2023 |
| CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 5MG;2.5MG | capsule · oral | ALEMBIC | Prescription | 15 Sep 2023 |
| CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 5MG;2.5MG | capsule · oral | WINDER LABS LLC | Prescription | 8 Jul 2024 |
| CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 5MG;2.5MG | capsule · oral | TEVA PHARMS USA | Discontinued | 2 Nov 2021 |
| CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 5MG;2.5MG | capsule · oral | TORRENT | Discontinued | 14 Dec 2023 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| LIBRAX | 00115630 | 2.5 MG; 5 MG | CAPSULE · ORAL | BAUSCH HEALTH, CANADA INC. |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | CHLORDIAZEPOXIDE-CLIDINIUM CAP | $0.25608 | per EA | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.